The present article delved into the potential of liquid biopsy to revolutionize cancer diagnostics and treatment by addressing the current challenges in the field. Liquid biopsy, a non-invasive procedure, involves the detection and analysis of biomarkers in bodily fluids, offering advantages over traditional tissue biopsies. It provides a promising solution to the need for real-time monitoring, personalized treatment approaches, early detection, and minimal residual disease assessment in cancer care. By exploring various applications, such as early detection, treatment monitoring, minimal residual disease assessment, genetic profiling, personalized medicine, and prognostic evaluation, liquid biopsy emerges as a valuable tool in advancing cancer diagnostics and treatment.
The present article also discussed current developments, future directions, and provided case studies and success stories showcasing the impact of liquid biopsy. Overall, liquid biopsy holds great promise in transforming cancer care by enabling early detection, personalized treatment decisions, and real-time monitoring of tumors.

Keywords: Early cancer detection; Liquid biopsy; Minimal residual disease assessment; Traditional tissue biopsy

DOI: 10.35755/jmedassocthai.2023.12.13918

Received 18 September 2023 | Revised 13 November 2023 | Accepted 15 November 2023